Another study utilizing a 68-antibody DSP panel to analyze B cell follicles in melanoma SLNs revealed significantly higher expression of multiple activation markers, including Ki-67, within B cell regions of metastatic SLNs compared to non-metastatic SLNs. The gene discussed is MKI67; the disease is melanoma.